Metraipolis › archive › dc_05cdba4759cc

Circulating free DNA as a predictive biomarker for response to nivolumab and platinum-based chemotherapy in metastatic esophageal adenocarcinoma: a… — Europe PMC PMID:41256319

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41256319
DOI
10.3389/fonc.2025.1678068
License (as archived)
solo-consultazione
Archived
2026-11-08T19:52:11.477Z
SHA-256 of the archived text
49fd572b5a1ffb9780c35ec8135d1d5e6f17f9a0a29008872ad5f541ce50faf9
Stable URL of this page
https://metraipolis.com/documento/dc_05cdba4759cc

How to cite

Circulating free DNA as a predictive biomarker for response to nivolumab and platinum-based chemotherapy in metastatic esophageal adenocarcinoma: a… — Europe PMC PMID:41256319 — Europe PMC (en), https://europepmc.org/article/MED/41256319 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_05cdba4759cc (Metraipolis archive dc_05cdba4759cc, sha256 49fd572b5a1ffb9780c35ec8135d1d5e6f17f9a0a29008872ad5f541ce50faf9)
BibTeX
@misc{dc05cdba4759cc,
  title = {Circulating free DNA as a predictive biomarker for response to nivolumab and platinum-based chemotherapy in metastatic esophageal adenocarcinoma: a… — Europe PMC PMID:41256319},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41256319},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_05cdba4759cc; sha256 49fd572b5a1ffb9780c35ec8135d1d5e6f17f9a0a29008872ad5f541ce50faf9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41256319. Agents can read the archived copy with the MCP tool read_document.